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Professor Phillips opened the meeting by drawing 
attention to the new European Directive on In Vitro 
Diagnostic Medlcal Devices (IVDMDs), which include 
materials, media, reagents as well as kits for anti- 
biotic sensitivity (or susceptibility) testing, as potential 
methods of documenting and reporting results. Within 
the Directive is the expectation that manufacturers of 
IVDMD’s will demonstrate their performance charac- 
teristics in the setting for which they are intended - that 
is, in clinical diagnostic laboratories. 
When the Directive comes into effect, CEN 
(Centre Europken de Normalisation) will be respons- 
ible for the introduction of European standards and, 
whenever possible, international standards. At present, 
the CEN Technical Committee 140 (TC140) on 
which ESCMID has a seat, along with representatives 
of national standard organizations, is waiting to be 
informed about progress towards professional consensus 
on sensitivity testing methods, including criteria for 
establishing breakpoints. 
Professor Phillips reminded the conference par- 
ticipants that the ESCMID study group on antibiotic 
breakpoints has been able to reach agreement on 
criteria for establishing breakpoints and has published 
proposed breakpoints for a number of new anti- 
microbial agents. In addition, there has been a number 
of meetings between representatives of different 
European countries as well as international discussions, 
such as that organized by ESCMID and ASM during 
last year’s ICAAC in Orlando. ESCMID and its study 
group on anaerobes (ESGAB) has also carried out 
multicenter, European studies on susceptibility testing 
of anaerobes. Further concerted action has been much 
more difficult to achieve. 
There followed a discussion to which 15 particip- 
ants from France (3 speakers), Germany (3),  Greece (1) 
the Netherlands (l), Norway (l), Spain (l), Sweden (l), 
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Switzerland (1) and the UK (3) contributed. It became 
clear that the achievement of sensitivity testing 
comparability and breakpoint determination of use to 
clinicians were, to most participants, two different, if 
related, goals. Virtually all supported the idea of co- 
operation to achieve comparability, but not standardiz- 
ation of methodology at this stage. This would require 
comparison of the performance of methods used in 
different diagnostic laboratories in different countries 
with that of reference methods. Both MIC determin- 
ations (in liquid and on solid media) and disk-diffusion 
methods should be included. Although a number of 
participants had little confidence in the latter, several 
spoke up for them, pointing out that they are, 
furthermore, very widely used. It was noted that the 
now inactive ECCLS had produced reference methods 
in 1989 and some considered that the method of 
Sherris et al., also has potential. The prospect of 
agreeing on a reference method for MIC determin- 
ation seemed good in the light of a considerable 
amount of earlier work and the current closeness to 
consensus. It  was also generally, but not universally, felt 
that it should be possible to devise a reference method 
for disk testing. At some future date, it will be necessary 
to consider newer and more innovative methods. The 
problem of detection of resistance mechanisms and 
small shifts in sensitivity was also noted. 
The following proposals for action were then agreed 
upon: 
Proposal 1 
(i) ESCMID should propose reference methods, 
initially for: 
(a) broth micro-dilution MIC determinations 
(b) solid medium disk diffusion testing 
(ii) ESCMID should devise multicenter studies in 
collaboration with the Chairmen of National 
Societies in Europe, and elsewhere with the 
advice of laboratory technologists and industry 
(including media, disk and appropriate kit manu- 
facturers) 
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(iii) 
(iv) 
the studies should allow comparison of a refer- 
ence method with all other methods (including 
NCCLS and variations on it) in common use in 
clinical laboratories, should use reference strains 
of bacteria (from readily accessible recognized 
collections, such as ATCC), and should also 
involve sensitivity testing of local isolates, locally 
and in one or more reference laboratories 
designated for that purpose. 
small project groups should be set up to organize 
and carry out the studies. 
Proposal 2 
While achieving comparability of laboratory methods, 
ESCMID should bring together national represen- 
tatives who will jointly: 
(a) identify and compare the criteria used in 
breakpoint determinations in different 
European countries. (A number of national 
societies have already documented their 
procedures) 
(b) identify and compare national breakpoints, 
updating the work of Baquero of a few years 
ago, and establish whether differences arise 
from: 
(i) variations in antimicrobial dosage in 
different countries, or differences in 
distribution of antibiotic susceptibility 
(ii) the use of different criteria for break- 
point determinations 
(c) determine whether it is possible to work 
with relevant pharmaceutical companies to 
identify tentative breakpoints (it has to be 
acknowledged that not all believe that the 
objective of “breakpoints for Europe” is 
either possible or desirable). 
Action 
The Society supports these proposals and invites any 
group interested in organizing or taking part in any of 
the studies, to contact the Society, who will co- 
ordinate the work of groups studying specific topics. 
The Society would also like to maintain an updated 
list of national and international studies related to 
susceptibility testing and breakpoint determinations: 
please keep us informed. 
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